Detalhe da pesquisa
1.
Spinal cord injury: Olfactory ensheathing cell-based therapeutic strategies.
J Neurosci Res
; 102(1): e25283, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38284859
2.
Benchmarking palliative care practices in neurooncology: a german perspective.
J Neurooncol
; 2024 May 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38696050
3.
[Vestibular Schwannoma: Factors in Therapy Decision-Making]. / Vestibularisschwannom: Faktoren bei der Therapieentscheidung.
Laryngorhinootologie
; 103(3): 176-186, 2024 03.
Artigo
Alemão
| MEDLINE | ID: mdl-38128578
4.
A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression.
Int J Cancer
; 152(2): 308-319, 2023 01 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36054558
5.
Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions.
Acta Neuropathol
; 145(5): 667-680, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36933012
6.
Radiomics for the non-invasive prediction of PD-L1 expression in patients with brain metastases secondary to non-small cell lung cancer.
J Neurooncol
; 163(3): 597-605, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-37382806
7.
The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trial.
J Neurooncol
; 164(3): 749-755, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-37787906
8.
Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses.
J Neurooncol
; 164(3): 607-616, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-37728779
9.
Rapid, label-free classification of glioblastoma differentiation status combining confocal Raman spectroscopy and machine learning.
Analyst
; 148(23): 6109-6119, 2023 Nov 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37927114
10.
Paradigm Shift in the Treatment of Meningiomas.
Adv Exp Med Biol
; 1416: 1-4, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37432615
11.
Recurrent brain metastases: the role of resection of in a comprehensive multidisciplinary treatment setting.
BMC Cancer
; 22(1): 275, 2022 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35291972
12.
Efficacy and tolerability of regorafenib in pretreated patients with progressive CNS grade 3 or 4 gliomas.
J Neurooncol
; 159(2): 309-317, 2022 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-35716310
13.
Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUS.
J Neurooncol
; 159(1): 95-101, 2022 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-35704157
14.
Ventriculostomy-related intracranial hemorrhage following surgical and endovascular treatment of ruptured aneurysms.
Neurosurg Rev
; 45(4): 2787-2795, 2022 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-35486198
15.
Transradial versus transfemoral access for endovascular therapy of intracranial aneurysms: a systematic review and meta-analysis of cohort studies.
Neurosurg Rev
; 45(6): 3489-3498, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36129583
16.
MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA-09 trial.
Int J Cancer
; 148(7): 1695-1707, 2021 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33113214
17.
Improving the efficacy and reliability of rTMS language mapping by increasing the stimulation frequency.
Hum Brain Mapp
; 42(16): 5309-5321, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34387388
18.
Impact of the weekend effect on outcome after microsurgical clipping of ruptured intracranial aneurysms.
Acta Neurochir (Wien)
; 163(3): 783-791, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33403431
19.
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
Lancet
; 393(10172): 678-688, 2019 02 16.
Artigo
Inglês
| MEDLINE | ID: mdl-30782343
20.
Invasive versus non-invasive mapping of the motor cortex.
Hum Brain Mapp
; 41(14): 3970-3983, 2020 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32588936